Skip to main content
NVDA+0.35%AAPL-0.01%GOOGL-0.61%MSFT+0.11%AMZN+0.12%TSM+0.96%SPCX+5.15%META+0.13%AVGO+0.07%TSLA+0.10%SKHY+0.02%BRK-B+0.59%LLY+0.18%MU+0.49%JPM-1.01%WMT-0.55%AMD+1.65%V-1.25%XOM-3.54%JNJ+0.03%ASMLa+1.26%INTC+4.03%0700.HK-1.23%MA-0.96%ABBV-0.17%1398.HK+0.67%CSCO-2.12%CVX-2.86%ORCL+2.00%BAC-2.72%COST-0.84%KO-0.95%DELL+3.64%CAT-0.10%0005.HK+0.81%PG+0.24%HSBA.L+0.27%UNH-0.18%LRCX-0.61%AP2d+0.95%AMAT-1.37%3988.HK+0.34%GE+1.91%1816.HK-0.69%MS-1.83%NFLX-1.91%0857.HK-1.90%HD-0.99%PM-1.24%0939.HK+0.31%USDJPY+1.75%NZDUSD-1.68%AUDUSD-1.19%EURUSD-1.15%USDCHF+1.14%GBPUSD-1.07%USDTHB+1.06%CADJPY+0.93%NZDCAD-0.86%USDCAD+0.84%CHFJPY+0.72%GBPJPY+0.63%GBPNZD+0.61%EURJPY+0.57%AUDJPY+0.56%NZDCHF-0.55%EURNZD+0.53%AUDNZD+0.50%GBPTRY+0.41%EURCAD-0.36%AUDCAD-0.35%GBPHKD+0.32%USDTRY+0.32%CADCHF+0.30%GBPMXN-0.28%GBPCAD-0.25%USDILS+0.16%GBPAUD+0.09%NZDMXN+0.07%USDCNH+0.07%NZDJPY+0.06%AUDSGD-0.06%USDZAR+0.06%EURAUD+0.05%EURGBP-0.05%AUDCHF-0.05%USDCOP-0.04%GBPSGD-0.04%GBPCHF+0.03%NZDSGD+0.03%USDSGD-0.03%USDMXN+0.03%USDHKD+0.02%EURSGD-0.02%SGDJPY+0.02%EURCHF0.00%CHFSGD0.00%EURPLN0.00%EURSEK0.00%GBPZAR0.00%PLNJPY0.00%USDSEK0.00%EURNOK0.00%EURDKK0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%AUDDKK0.00%CHFSEK0.00%EURCZK0.00%USDPLN0.00%NOKJPY0.00%CHFNOK0.00%USDNOK0.00%USDDKK0.00%XPTUSD+0.50%USOIL-0.34%XNGUSD+0.23%XAGUSD-0.16%GAGUSD-0.16%GAUUSD-0.14%XAUUSD-0.14%HG1+0.07%C10.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.30%ETHUSD+0.05%USDTUSD+0.01%XRPUSD+0.24%SOLUSD+1.16%TRXUSDT+0.85%ZECUSDT+19.00%DOGEUSD+0.39%XMRUSDT-3.33%LINKUSD+0.11%XLMUSD+2.39%BCHUSDT+0.64%UNIUSD+0.99%LTCUSD+0.01%TONUSD+29.54%HBARUSDT-1.78%SUIUSD+2.48%TAOUSDT+0.91%AAVEUSD-2.45%DOTUSDT+6.24%ICPUSDT+1.16%ONDOUSDT+3.23%WLDUSDT+1.83%ARBUSDT+7.51%ATOMUSDT-1.34%JUPUSDT-1.19%INJUSDT-1.15%STXUSDT+2.00%FETUSDT+2.77%PYTHUSDT-1.32%TIAUSDT+2.70%SEIUSDT+1.07%IMXUSDT-1.25%GRTUSDT+1.74%OPUSDT-0.14%WIFUSDT+1.40%POLUSDT+1.05%IOTAUSDT-0.87%AXSUSDT+0.03%FARTCOINUSDT-0.86%EOSUSDT-0.44%DYDXUSDT-0.14%ORDIUSDT+2.66%GALAUSDT-2.76%NOTUSDT+1.37%RONINUSDT-2.40%NVDA+0.35%AAPL-0.01%GOOGL-0.61%MSFT+0.11%AMZN+0.12%TSM+0.96%SPCX+5.15%META+0.13%AVGO+0.07%TSLA+0.10%SKHY+0.02%BRK-B+0.59%LLY+0.18%MU+0.49%JPM-1.01%WMT-0.55%AMD+1.65%V-1.25%XOM-3.54%JNJ+0.03%ASMLa+1.26%INTC+4.03%0700.HK-1.23%MA-0.96%ABBV-0.17%1398.HK+0.67%CSCO-2.12%CVX-2.86%ORCL+2.00%BAC-2.72%COST-0.84%KO-0.95%DELL+3.64%CAT-0.10%0005.HK+0.81%PG+0.24%HSBA.L+0.27%UNH-0.18%LRCX-0.61%AP2d+0.95%AMAT-1.37%3988.HK+0.34%GE+1.91%1816.HK-0.69%MS-1.83%NFLX-1.91%0857.HK-1.90%HD-0.99%PM-1.24%0939.HK+0.31%USDJPY+1.75%NZDUSD-1.68%AUDUSD-1.19%EURUSD-1.15%USDCHF+1.14%GBPUSD-1.07%USDTHB+1.06%CADJPY+0.93%NZDCAD-0.86%USDCAD+0.84%CHFJPY+0.72%GBPJPY+0.63%GBPNZD+0.61%EURJPY+0.57%AUDJPY+0.56%NZDCHF-0.55%EURNZD+0.53%AUDNZD+0.50%GBPTRY+0.41%EURCAD-0.36%AUDCAD-0.35%GBPHKD+0.32%USDTRY+0.32%CADCHF+0.30%GBPMXN-0.28%GBPCAD-0.25%USDILS+0.16%GBPAUD+0.09%NZDMXN+0.07%USDCNH+0.07%NZDJPY+0.06%AUDSGD-0.06%USDZAR+0.06%EURAUD+0.05%EURGBP-0.05%AUDCHF-0.05%USDCOP-0.04%GBPSGD-0.04%GBPCHF+0.03%NZDSGD+0.03%USDSGD-0.03%USDMXN+0.03%USDHKD+0.02%EURSGD-0.02%SGDJPY+0.02%EURCHF0.00%CHFSGD0.00%EURPLN0.00%EURSEK0.00%GBPZAR0.00%PLNJPY0.00%USDSEK0.00%EURNOK0.00%EURDKK0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%AUDDKK0.00%CHFSEK0.00%EURCZK0.00%USDPLN0.00%NOKJPY0.00%CHFNOK0.00%USDNOK0.00%USDDKK0.00%XPTUSD+0.50%USOIL-0.34%XNGUSD+0.23%XAGUSD-0.16%GAGUSD-0.16%GAUUSD-0.14%XAUUSD-0.14%HG1+0.07%C10.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.30%ETHUSD+0.05%USDTUSD+0.01%XRPUSD+0.24%SOLUSD+1.16%TRXUSDT+0.85%ZECUSDT+19.00%DOGEUSD+0.39%XMRUSDT-3.33%LINKUSD+0.11%XLMUSD+2.39%BCHUSDT+0.64%UNIUSD+0.99%LTCUSD+0.01%TONUSD+29.54%HBARUSDT-1.78%SUIUSD+2.48%TAOUSDT+0.91%AAVEUSD-2.45%DOTUSDT+6.24%ICPUSDT+1.16%ONDOUSDT+3.23%WLDUSDT+1.83%ARBUSDT+7.51%ATOMUSDT-1.34%JUPUSDT-1.19%INJUSDT-1.15%STXUSDT+2.00%FETUSDT+2.77%PYTHUSDT-1.32%TIAUSDT+2.70%SEIUSDT+1.07%IMXUSDT-1.25%GRTUSDT+1.74%OPUSDT-0.14%WIFUSDT+1.40%POLUSDT+1.05%IOTAUSDT-0.87%AXSUSDT+0.03%FARTCOINUSDT-0.86%EOSUSDT-0.44%DYDXUSDT-0.14%ORDIUSDT+2.66%GALAUSDT-2.76%NOTUSDT+1.37%RONINUSDT-2.40%
HU

Humacyte, Inc. (HUMA)

NASDAQ • Healthcare

$0.56
+$0.01 (+3.3%)
Market closed

Last close at September 16, 2026 at 20:00 UTC

Open$0.56
Day Range$0.55 - $0.59
Avg. Volume (3M)6.3M
Market Cap$95.7M
52 Week Range
$0.53$2.55
Next EarningsIn 56 daysNov 11, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$2.1M
Net Income (TTM)
-$96.7M
EPS (TTM)
-$0.51
ROA (TTM)
-70.05%
Current Ratio
6.21

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

0.0%Q1 2026-$0.13
+10.0%Q2 2026-$0.09
-41.0%Q3 2026-$0.16
Next

Nov 11

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -41.0%

Humacyte's fiscal second quarter of 2026, reported Aug. 12, came in below consensus on both EPS and revenue, with EPS of -$0.16 trailing the -$0.11 estimate, -41%, and revenue of $406,000 trailing the $1.0 million estimate, -61%. Revenue rose about 35% to about $406,000 from $301,000 a year earlier, while operating loss was about $27.0 million and net income was a loss of about $36.8 million, up 2.3% from a $37.7 million loss a year earlier. Consensus for the next period calls for EPS of -$0.09 on revenue of $1.0 million.

View full earnings history

About Humacyte, Inc.

Humacyte, Inc. (NASDAQ: HUMA) is a healthcare biotechnology company that develops and manufactures implantable human tissues engineered in a laboratory setting. In qualitative terms, it is an early-commercial-stage regenerative-medicine business built around human acellular vessels for vascular repair, reconstruction, and replacement.

Name
Humacyte, Inc.
CEO
Laura E. Niklason
Website
www.humacyte.com
Industry
Healthcare
Year Founded
2004
Employees
184

Today's Snapshot

AI-generated

HUMA closed 3.3% higher on heavier trading than usual. Humacyte highlighted its plans for dialysis access at an investor conference.

Trading Volume

Above 10d avg 3.3M

4.9M

vs S&P 500 Today

Strong Outperformance

+3.92%

Updated: September 16, 2026 at 20:29 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
HUMA is priced around $0.57 and exhibits broadly bearish structure as short- and medium-term averages remain above the market and the 200-day series sits substantially higher, signaling longer-term overhead pressure. Momentum measures are tepid to negative and MACD is slightly below zero, while RSI sits below neutral and trend strength is weak. Volatility is elevated for the share price level and on-balance volume is heavily negative, although a pivot sits near the current price and some oscillators show very short-term oversold readings. Technical takeaway: Sell posture amid weak trend and heavy volume.
All signals
  • EMA (5 indicators)$0.58 - $0.95
    Sell
  • RSI (14)42.26
    Neutral
  • Stochastic %K (14, 3, 3)10.23
    Buy
  • MACD Level (12, 26)-0.03
    Sell

Peers & Related Assets

ARCTArcturus Therapeutics Holdings Inc.
$15.6-1.5%
AVIRAtea Pharmaceuticals, Inc.
$5.15-1.5%
VNDAVanda Pharmaceuticals Inc.
$5+0.2%
TRDAEntrada Therapeutics, Inc.
$6.89+0.1%
VYGRVoyager Therapeutics, Inc.
$3.05-1.3%
ACHVAchieve Life Sciences, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.